Filtered By:
Countries: USA Health
This page shows you your search results in order of date. This is page number 16.
Order by Relevance | Date
Total 380 results found since Jan 2013.
SC2 Trends in Diagnostic Prevalence, Treatment Patterns, and Healthcare Resource Utilization of Pediatric Food Allergy Patients in the United States, 2008-2018
This study aimed to analyze diagnostic prevalence rates, treatment patterns, and healthcare resource utilization (HCRU) of FA among the United States pediatric insured population from 2008 to 2018.
Source: Value in Health - June 1, 2021 Category: International Medicine & Public Health Authors: K. Mills, C. Nowak, C. Choong, M. Shan, M. Hoyt, T. Hunter Source Type: research
PRS19 Trends in Diagnostic Prevalence, Treatment Patterns, and Healthcare Resource Utilization of Adult Patients with Food Allergies in the United States, 2008-2018
This study aimed to analyze the annual diagnostic prevalence rates, treatment patterns, and healthcare resource utilization (HCRU) of adult patients with food allergies in the United States from 2008-2018.
Source: Value in Health - June 1, 2021 Category: International Medicine & Public Health Authors: T. Hunter, C. Nowak, M. Shan, M. Hoyt, C. Choong, K. Mills Source Type: research
IJERPH, Vol. 18, Pages 4945: Exposures in the Indoor Environment and Prevalence of Allergic Conditions in the United States of America
This study confirms previous relationships and reports novel associations, generating hypotheses for future research.
Source: International Journal of Environmental Research and Public Health - May 6, 2021 Category: Environmental Health Authors: Janvier Gasana Boubakari Ibrahimou Ahmed N. Albatineh Mustafa Al-Zoughool Dina Zein Tags: Article Source Type: research
Johnson & Johnson Single-Shot COVID-19 Vaccine Phase 3 Data Published in New England Journal of Medicine
NEW BRUNSWICK, N.J., April 21, 2021 – Johnson & Johnson (the Company) today announced publication in the New England Journal of Medicine of primary data from the Phase 3 ENSEMBLE clinical trial for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen). The publication of the primary analysis follows the topline efficacy and safety data announced in January, showing the trial met all primary and key secondary endpoints, and found that the Johnson & Johnson single-dose COVID-19 vaccine prevented hospitalization and death across all study participants ...
Source: Johnson and Johnson - April 21, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news
Is It Allergies or COVID? Expert Shows How to Tell the Difference
MONDAY, April 19, 2021 -- Seasonal allergies are striking this year at the worst possible time, with the United States in the midst of a fourth wave of the global COVID-19 pandemic.
You ' ve got an itchy nose and watery eyes. Or maybe you ' ve got a...
Source: Drugs.com - Daily MedNews - April 19, 2021 Category: General Medicine Source Type: news
The Pandemic Remade Every Corner of Society. Now It ’s the Climate’s Turn
On her third day as the Secretary of Housing and Urban Development, Marcia Fudge phoned the White House. She had taken over an agency with a role to play addressing a range of crises as the lack of affordable housing in U.S. cities has left hundreds of thousands homeless and millions more in financial straits. She connected with Joe Biden’s climate team. Fudge and Gina McCarthy, Biden’s national climate adviser, talked about addressing climate change and the affordable-housing shortage at the same time. Three weeks later, the Administration announced plans to provide for more than 1 million resilient and e...
Source: TIME: Science - April 15, 2021 Category: Science Authors: Justin Worland Tags: Uncategorized climate change Cover Story feature Magazine TIME 2030 Source Type: news
Is fluoride varnish safe?: Validating the safety of fluoride varnish
CONCLUSIONS: Given the widespread use of fluoride varnish in the United States, the number of AEs reported to the US Food and Drug Administration were few. Thus fluoride varnish can be considered a safe dental product.PRACTICAL IMPLICATIONS: Provides data on the safety of fluoride varnish that can be used by the dental profession to allay concerns by nondental providers and patients on this important caries preventive measure.PMID:33766405 | DOI:10.1016/j.adaj.2021.01.013
Source: Journal of the American Dental Association - March 26, 2021 Category: Dentistry Authors: Ana Karina Mascarenhas Source Type: research
Johnson & Johnson Announces U.S. CDC Advisory Committee Recommends First Single-Shot COVID-19 Vaccine for Adults 18 and Older in U.S.
NEW BRUNSWICK, N.J., February 28, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has recommended the first single-shot COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, for individuals 18 years of age and older under the Emergency Use Authorization (EUA) issued by the U.S. Food and Drug Administration (FDA). “For more than 130 years, Johnson & Johnson has come to the aid of people during times of crisis, and we believe today’s re...
Source: Johnson and Johnson - February 28, 2021 Category: Pharmaceuticals Source Type: news
Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use
NEW BRUNSWICK, N.J., February 27, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 years of age and older. This decision was based on the totality of scientific evidence, including data from the Phase 3 ENSEMBLE study that demonstrated the vaccine was 85 percent effective in preventing severe disease across all regions studied, and showed protection against ...
Source: Johnson and Johnson - February 28, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news
Allergies Are Nothing To Sneeze At As Global Warming Triggers Earlier Pollen
Across the United States and Canada, pollen season is starting 20 days earlier and pollen loads are 21% higher since 1990.
Source: Science - The Huffington Post - February 8, 2021 Category: Science Source Type: news
Forecasting Airborne Pollen for Allergy Management for Contiguous United States
Management of pollen allergies can be improved with a skillful forecast of pollen concentrations by allowing allergy sufferers to plan and prepare medical therapy and practice exposure avoidance. In the past, pollen forecasts have been limited spatially and temporally in the contiguous US.
Source: Journal of Allergy and Clinical Immunology - February 1, 2021 Category: Allergy & Immunology Authors: Jeremy Hess, Fiona Lo Source Type: research
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021.
This report summarizes the clinical and epidemiologic characteristics of case reports of allergic reactions, including anaphylaxis and nonanaphylaxis allergic reactions, after receipt of the first dose of Moderna COVID-19 vaccine during December 21, 2020-January 10, 2021, in the United States. CDC has issued updated interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United States (3) and interim considerations for preparing for the potential management of anaphylaxis (4).
PMID: 33507892 [PubMed - as supplied by publisher]
Source: MMWR Morb Mortal Wkl... - January 29, 2021 Category: Epidemiology Authors: CDC COVID-19 Response Team, Food and Drug Administration Tags: MMWR Morb Mortal Wkly Rep Source Type: research
New Innovation to Address System Overload by Systemizing the Field Triage and Treatment of Non-Emergent Patients
Introductory Note from JEMS Editor Emeritus A.J. Heightman, MPA, EMT-P
JEMS has prided itself on introducing countless groundbreaking concepts and innovations to the EMS community since its inception in 1980. As an example, in May 1980, JEMS introduced Jack Stout’s Public Utility Model and System Status management which changed the way many EMS Systems operated. His concepts introduced new ways to maximize resources and revenue through changes in the deployment of crews and resources.
In Feb. of 1981, Dr. Jeff Clawson’s dispatch priority training and the Medical Priority Dispatch System (MPDS); the impact and des...
Source: JEMS Patient Care - January 18, 2021 Category: Emergency Medicine Authors: Marc Eckstein, MD, MPH Tags: Administration and Leadership Communications & Dispatch Exclusives California EMS Prehospital Telemedicine Source Type: news
